- Home
- ATHA vs MGYR Comparison
ATHA vs MGYR Comparison
Compare ATHA & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- MGYR
- Stock Information
- Founded
- ATHA 2011
- MGYR 1922
- Country
- ATHA United States
- MGYR United States
- Employees
- ATHA N/A
- MGYR N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- MGYR Savings Institutions
- Sector
- ATHA Health Care
- MGYR Finance
- Exchange
- ATHA Nasdaq
- MGYR Nasdaq
- Market Cap
- ATHA 93.5M
- MGYR 77.6M
- IPO Year
- ATHA 2020
- MGYR 2006
- Fundamental
- Price
- ATHA $0.67
- MGYR $12.87
- Analyst Decision
- ATHA Buy
- MGYR
- Analyst Count
- ATHA 4
- MGYR 0
- Target Price
- ATHA $11.25
- MGYR N/A
- AVG Volume (30 Days)
- ATHA 14.2M
- MGYR 2.8K
- Earning Date
- ATHA 11-07-2024
- MGYR 10-31-2024
- Dividend Yield
- ATHA N/A
- MGYR 1.55%
- EPS Growth
- ATHA N/A
- MGYR 2.51
- EPS
- ATHA N/A
- MGYR 1.23
- Revenue
- ATHA N/A
- MGYR $31,497,000.00
- Revenue This Year
- ATHA N/A
- MGYR N/A
- Revenue Next Year
- ATHA N/A
- MGYR N/A
- P/E Ratio
- ATHA N/A
- MGYR $10.46
- Revenue Growth
- ATHA N/A
- MGYR 4.87
- 52 Week Low
- ATHA $0.41
- MGYR $9.57
- 52 Week High
- ATHA $4.30
- MGYR $13.00
- Technical
- Relative Strength Index (RSI)
- ATHA 51.78
- MGYR 69.52
- Support Level
- ATHA $0.60
- MGYR $12.31
- Resistance Level
- ATHA $0.83
- MGYR $12.97
- Average True Range (ATR)
- ATHA 0.10
- MGYR 0.15
- MACD
- ATHA 0.03
- MGYR 0.07
- Stochastic Oscillator
- ATHA 61.60
- MGYR 84.72
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
About MGYR Magyar Bancorp Inc.
Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.